ANA MARÍA
IGLESIAS PÉREZ
Hospital Universitario Puerta de Hierro
Madrid, EspañaHospital Universitario Puerta de Hierro -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2015
-
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433